News

Primary tabs

  • Cochrane South Africa announces appointment of new Director
    We are very pleased to announce that Cochrane South Africa has appointed Charles Shey Wiysonge as its new Director, effective December 2016. The Founding Director of Cochrane South Africa, Jimmy Volmink, will be stepping down from managing day-to-day operations at the Centre, but will continue to serve as Chair of the Global Organizing Committee…
    January 3 2017
  • Consumer involvement in Cochrane and why we are developing a Statement of Principles
    Richard Morley is Cochrane's Consumer Co-ordinator. Cross-posted, with permission, from the Cochrane Consumer Network site. In 2015 the Cochrane Consumer Network took a hard look at the state of consumer involvement in Cochrane and found much to celebrate: a long history of consumer involvement, going back to the start of Cochrane a network of…
    December 23 2016
  • Third round of the Cochrane Review Support Programme funds 10 new reviews
    We are pleased to announce the 10 successful titles from the third Cochrane Review Support Programme (CRSP) funding round. Airway physical examination tests for detection of difficult airway management in apparently normal patients (Anaesthesia, Critical and Emergency Care)   Atraumatic restorative treatment versus conventional restorative…
    December 21 2016
  • Call for consultation: Consumer involvement in Cochrane
    Consultation on the draft document “Consumer involvement in Cochrane: developing the Statement of Principles”  Closing date for feedback: 31 December 2016   Dear colleagues, During 2015, the Cochrane Consumer Network undertook its Structure and Function Review, examining key elements about consumer involvement in Cochrane, and the ways in…
    December 8 2016
  • Heart Group: targeting consumers on World Heart Day
    This is the fourth in a series of Cochrane Blog posts about prioritization work by Cochrane Review Groups. You can read more about the project and the full series of blog post  on the project page. Until recently Cochrane Heart worked mainly with expert clinicians in an internal prioritization activity. For example, between May and August 2016…
    December 6 2016
  • Communicating complex evidence: the danger of the misrepresentation and misuse of evidence
    Howard White is the CEO of the Campbell Collaboration. Cross-posted, with permission, from the Campbell Blog. The National Institute for Clinical Evidence (NICE) has produced new consultation guidance on ‘Air pollution - outdoor air quality and health’. Not very newsworthy you might think. Well you’d be wrong. The Telegraph (UK) ran the story on…
    December 6 2016
  • Join the Cochrane Crowd 48 hour Citation Screening Challenge!
    Cochrane Crowd , Cochrane’s new citizen science platform, is a global community of almost 4,000 volunteers who are helping to classify the research needed to support informed decision-making about healthcare treatments. Cochrane Crowd would like your help to achieve one million classifications  by the end of the year. Help Cochrane Crowd get over…
    December 6 2016
  • Cochrane and Epistemonikos announce partnership
    Cochrane and the Epistemonikos Foundation are delighted to announce the launch of our official partnership aimed at improving the knowledge base for making decisions in health care and global health policy. The close alignment of objectives, values, products, and services between Cochrane and Epistemonikos has existed for some years. Both…
    December 5 2016
  • Sexually Transmitted Infections Group: priority setting in a low/middle income country
    This is the third in a series of Cochrane Blog posts about prioritization work by Cochrane Review Groups. You can read more about the project and the full series of blog post  on the project page. The Cochrane Sexually Transmitted Infections (STI) Group moved to Bogota, Colombia in 2012, where it is now part of the School of Medicine at the…
    December 1 2016
  • Update on central support for EU funding
    Angéline Serre, EU Funding Coordinator, is leaving Cochrane to take up a one-year position at Bordeaux University. Her last day will be January 12. Given the ongoing uncertainty for EU funding of UK Cochrane Groups, as well as the central team, due to Brexit, we have been in discussions about what central support was appropriate given that many…
    November 29 2016
Subscribe to News